CDTX vs ROP · rev $1.3M vs P/E 41, rev $1.88B
Cidara Therapeutics Inc (CDTX) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
CDTX currently screens at market cap $6.96B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the CDTX and ROP stock pages for the full models.
Not investment advice.